At a glance
Complex
This grant is designed to support clinical trials that test the safety and effectiveness of new treatments for rare diseases. The goal is to help develop more approved treatments for these diseases by funding innovative and collaborative trials.
Who it's for: This grant is for organizations that conduct clinical trials, specifically those focused on developing new treatments for rare diseases. This could include research institutions, hospitals, or other entities involved in medical research.
More details
Likely Disqualifiers
- Proposals not focused on rare diseases
- Lack of a clinical trial component
- Applications not demonstrating unmet needs
- Projects outside the scope of new indications or labeling changes
- Incomplete applications
What You May Need
- Detailed project proposal
- Clinical trial design
- Budget justification
- Proof of unmet needs in rare diseases
- Organizational capability statement
- Letters of support or collaboration
- Regulatory compliance documentation
- Previous research findings
- Institutional Review Board (IRB) approval
- FDA regulatory pathway plan
Cautions
- Ensure the focus is on rare diseases
- Must include a clinical trial component
- Application must clearly demonstrate unmet needs
- Compliance with FDA regulations is critical
- Projects must aim for new indications or labeling changes